Healthcare
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Trend Stats
1-Month Return
+5.74%
3-Month Return
+14.65%
12-Month Return
+25.02%
Volatility Score
1.7
RSI
62.1
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Healthcare
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1.1T | +69.36% | +17.60% | +2.54% | 3.4 | Neutral | Up |
| JNJ | Johnson&Johnson | $627B | +51.07% | +13.45% | +2.56% | 2.2 | Up | Up |
| ABBV | AbbVie | $441B | +24.44% | +19.20% | +2.64% | 2.4 | Neutral | Up |
| UNH | Unitedhealth Gro | $361B | +35.68% | +1.24% | -5.52% | 2.7 | Down | Up |
| MRK | Merck | $335B | +66.70% | +20.64% | +12.47% | 2.4 | Up | Up |
| AMGN | Amgen | $225B | +44.26% | +24.42% | +16.88% | 2.8 | Up | Up |
| TMO | Thermo Fisher Sc | $218B | +20.74% | +31.38% | +10.15% | 2.9 | Up | Up |
| ABT | Abbott Laborator | $193B | -13.61% | +31.97% | +25.95% | 2.4 | Up | Up |
| GILD | Gilead Sciences | $172B | +19.93% | +5.46% | +6.40% | 2.8 | Up | Up |
| PFE | Pfizer | $153B | +14.04% | +5.86% | +12.41% | 2.0 | Up | Up |
| DHR | Danaher | $142B | -3.31% | +23.30% | +1.71% | 3.9 | Up | Down |
| ISRG | Intuitive Surgic | $139B | -17.85% | -7.84% | +3.96% | 3.5 | Neutral | Down |
| BMY | Bristol-MyersSqu | $130B | +38.10% | +13.71% | +12.08% | 2.7 | Up | Up |
| SYK | Stryker | $130B | -10.28% | +11.33% | +9.05% | 3.1 | Up | Down |
| VRTX | Vertex Pharma | $128B | +28.76% | +12.29% | +6.18% | 2.9 | Up | Up |
| CVS | CVS Health | $124B | +46.13% | +0.63% | -7.93% | 2.9 | Down | Up |
| MDT | Medtronic | $117B | +1.31% | +19.65% | +15.09% | 2.3 | Up | Up |
| MCK | Mckesson | $101B | +29.64% | +16.42% | +8.17% | 3.1 | Up | Up |
| HCA | HCA Healthcare | $88B | +2.94% | -6.29% | +11.30% | 3.0 | Up | Down |
| ELV | Elevance Health | $87B | +32.03% | +1.32% | -6.20% | 2.8 | Neutral | Up |
| REGN | Regeneron Pharma | $83B | +39.19% | +12.88% | +22.46% | 2.6 | Up | Up |
| BSX | Boston Scientifi | $75B | -49.76% | -3.21% | +21.58% | 3.2 | Up | Down |
| CI | The Cigna | $75B | -2.71% | -3.64% | -6.85% | 2.9 | Down | Neutral |
| COR | Cencora | $60B | +7.99% | +20.70% | +4.02% | 2.9 | Up | Down |
| CAH | Cardinal Health | $55B | +58.82% | +21.25% | +2.20% | 2.6 | Neutral | Up |
| EW | Edwards Lifescns | $53B | +17.05% | +12.61% | +1.68% | 2.5 | Up | Up |
| BDX | Becton Dickinson | $50B | -4.10% | +27.84% | +21.74% | 2.4 | Up | Up |
| HUM | Humana | $47B | +37.81% | +29.41% | -4.36% | 3.8 | Neutral | Up |
| IDXX | IDEXX Labs | $43B | -15.35% | +3.40% | +1.90% | 3.5 | Down | Down |
| A | Agilent Tech | $42B | +25.61% | +31.39% | +9.86% | 2.6 | Up | Up |
| WAT | Waters | $40B | +41.37% | +23.70% | +9.51% | 3.2 | Up | Up |
| VEEV | Veeva Systems-A | $40B | -13.14% | +56.00% | +26.24% | 3.7 | Up | Up |
| IQV | IQVIA Holdings | $39B | +23.85% | +38.66% | +13.87% | 3.8 | Up | Up |
| DXCM | Dexcom | $34B | +10.87% | +55.22% | +21.09% | 3.3 | Up | Up |
| CNC | Centene | $33B | +136.82% | +14.94% | -1.82% | 4.2 | Up | Up |
| GEHC | GE Hltc Tech | $33B | +0.59% | +17.65% | +19.58% | 3.0 | Up | Neutral |
| RMD | Resmed | $32B | -20.61% | +10.87% | +16.29% | 3.2 | Up | Down |
| BIIB | Biogen | $31B | +51.39% | +9.65% | +9.31% | 3.1 | Up | Up |
| ZTS | Zoetis-A | $30B | -51.20% | -1.56% | +0.32% | 3.9 | Down | Down |
| MTD | Mettler Toledo I | $28B | +8.13% | +36.19% | +7.92% | 2.9 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |